<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Barefoot | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/visionkayak62/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/visionkayak62/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Barefoot.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">4f01284488bbd7370f41b406f922d080</guid>
				<title>Barefoot posted an update: Body composition may explain partially why non-obese [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42879/</link>
				<pubDate>Sun, 09 Feb 2025 11:48:36 -0800</pubDate>

									<content:encoded><![CDATA[<p>Body composition may explain partially why non-obese individuals still at the risk of developing non-alcoholic fatty liver disease (NAFLD). The ratio of fat mass to fat-free mass (FM/FFM) has been proposed to assess the combined effect of different body compositions.</p>
<p> We aimed to investigate the associations of FM/FFM ratio with the risk of&hellip;<span class="activity-read-more" id="activity-read-more-42879"><a href="http://www.nationalboardinstitute.com/activity/p/42879/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">adc5a1b812f458a75a52a99b87fb0cf0</guid>
				<title>Barefoot posted an update: Our study demonstrates that computational protein design [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40113/</link>
				<pubDate>Thu, 06 Feb 2025 13:20:17 -0800</pubDate>

									<content:encoded><![CDATA[<p>Our study demonstrates that computational protein design provides powerful new tools to solve challenging protein engineering problems.</p>
<p> To determine whether patients with epilepsy (PWE) are particularly over-represented in a very large cohort of patients with COVID-19. We also investigated whether COVID-19 is associated with a different&hellip;<span class="activity-read-more" id="activity-read-more-40113"><a href="http://www.nationalboardinstitute.com/activity/p/40113/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">af7c4ac0bdc436e290baeb1bed2bb18b</guid>
				<title>Barefoot posted an update: 0%. The number of detected markers was correlated with the [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36652/</link>
				<pubDate>Sun, 02 Feb 2025 11:32:59 -0800</pubDate>

									<content:encoded><![CDATA[<p>0%. The number of detected markers was correlated with the cancer stage, perineural invasion, lymphatic emboli, and venous invasion. Our five-marker panel with the droplet digital MethyLight assay showed a high sensitivity and specificity for the detection of CRC with cfDNA samples from patients with metastatic CRC.The influence of muscular&hellip;<span class="activity-read-more" id="activity-read-more-36652"><a href="http://www.nationalboardinstitute.com/activity/p/36652/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">291e9b3ce3c265710af43319a81b3e24</guid>
				<title>Barefoot posted an update: Patients were also reviewed after 5 to 6 years at latest [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34789/</link>
				<pubDate>Fri, 31 Jan 2025 11:31:23 -0800</pubDate>

									<content:encoded><![CDATA[<p>Patients were also reviewed after 5 to 6 years at latest follow-up for final outcome. Results No severe adverse event was recalled as related to the ATMP. At 12 months, 16/20 per protocol and 16/22 under intention-to-treat (2 drop-out at 3 and 5 months) maintained head sphericity and showed bone regeneration. Of the 4 hips with ON progression, 3&hellip;<span class="activity-read-more" id="activity-read-more-34789"><a href="http://www.nationalboardinstitute.com/activity/p/34789/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">74d315e146faaf73178bc3d5215aba87</guid>
				<title>Barefoot posted an update: Infection is a common complication after the thread-lifting [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/29454/</link>
				<pubDate>Tue, 28 Jan 2025 13:10:27 -0800</pubDate>

									<content:encoded><![CDATA[<p>Infection is a common complication after the thread-lifting procedure, but the late-onset chronic purulent skin and soft tissue infection (SSTIs) after nonabsorbable thread lifting is quite rare.</p>
<p> To alert physicians should be aware of this kind of late-onset complication after nonabsorbable thread lifting.</p>
<p> A 54-year-old woman who&hellip;<span class="activity-read-more" id="activity-read-more-29454"><a href="http://www.nationalboardinstitute.com/activity/p/29454/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">dc0f0f1d0387b8965a8351ba4efa2d70</guid>
				<title>Barefoot became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/29378/</link>
				<pubDate>Tue, 28 Jan 2025 13:06:38 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>